Maija Itälä-Remes
MD, PhD, Adjunct professor
hematologia; akuutti leukemia; kantasolujensiirto
Academic degrees:
Medical doctor 26.5.1986, University of Turku, Finland
Doctoral thesis (”B-cell Chronic Lymphocytic Leukemia and Increased Susceptibility to Infections”) and 13.9.1996, University of Turku
Doctorate, PhD 4.12.1997, University of Turku
Adjunct professor Internal Medicine/Clinical Haematology 18.4.2005, University of Turku
Professional appointments:
Resident/specialist in Internal Medicine and in Anaesthesia 1986-1997 Turku University Central Hospital.
Clinical haematologist, Turku University Central Hospital 1997-2007.
Medical Adviser, Janssen-Cilag, Nordic Section 2007-2008.
Head of Department of Haematology, Tampere University Central Hospital 2008-2010.
Head of Stem Cell Transplant Unit, Turku University Hospital 2010-2017.
Head of Stem Cell Transplant Unit, Helsinki University Hospital 2017-2018.
Head of Division of Clinical Haematology and Stem Cell Transplant Unit, Programme Director of Stem Cell Transplant Unit, Turku University Central Hospital 2018-
Dissertations:
Supervisor 3, Opponent 2, Reviewer 4
Other academic appontments:
Review of the scientific work for docent application
Appointments in Scientific Societies:
Chair of the Finnish Society of Haematology 2012-2014, member 2014-.
Chair of the Finnish Acute Leukemia Working Group 2015-2018, member 2018-
The Nordic-Dutch Working Group for CLL (Chronic Lymphocytic Leukemia) Group, member 2000-2014.
The Finnish Haematology Registry and Biobank, member of the Steering group 2012-2014.
The European Group for Blood and Marrow Transplantation, member 1997-
Duties with National Authorities:
Consultant of the Parliament (Implementation of EU directives into National legislation) 2006-2007
Consultant of the Ministry of Social Affairs and Health (STM) 2016
Consultant of the Finnish Medicine Agency (Fimea) 2016-2018
EU consultation Brussels 2017
Activities in Quality Management:
Inspector exam of FACT/JACIE Quality Management System 31.5.2011, Rotterdam.
Establishment of the Quality Management System of the Stem Cell Unit of Turku University Hospital 2006; Moderation of initial JACIE accreditation and two re-accreditations 2006-2017 Turku University Central Hospital, Turku.
Scientific publications and text book articles in field of stem cell transplantions and haematological malignancies
Principal Investigator and Sub-investigator of International Multicentre Clinical Trials
GCP training, latest update 22.2.2018
Lectures at Finnish University Hospitals and Central Hospitals
Public lectures
Lectures at International meetings
Education of residents and junior colleagues (Clinical haematology and Stem Cell Transplantations)
Member of Faculty of the International Congress on Stem Cell Transplantation and Cellular Therapies, Berlin 2017
- Treatment Patterns and Clinical Outcomes of Patients with Moderate to Severe Acute Graft-Versus-Host Disease : A Multicenter Chart Review Study (2024)
- Hematology Reports
(A1 Vertaisarvioitu data-artikkeli tieteellisessä lehdessä) - Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms (2024)
- Blood Advances
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Young (<35 years) haploidentical versus old (≥35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2024)
- Bone Marrow Transplantation
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Younger unrelated donors may be preferable over HLA match in the PTCy era: A study from the ALWP of the EBMT (2024)
- Blood
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Cardiovascular morbidity following conventional therapy versus allogeneic hematopoietic stem cell transplantation after childhood, adolescent, and young adult leukemia in Finland (2023)
- International Journal of Cancer
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients (2023)
- Bone Marrow Transplantation
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study (2023)
- Blood Advances
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia (2023)
- Haematologica
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT (2023)
- Haematologica
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2023)
- Bone Marrow Transplantation
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study (2023)
- European Journal of Haematology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation (2023)
- Haematologica
(B1 Vertaisarvioimaton kirjoitus tieteellisessä lehdessä ) - Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party of the EBMT (2023)
- HemaSphere
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Burden of hospitalizations and outpatient visits associated with moderate and severe acute graft-versus-host disease in Finland and Sweden: a real-world data study (2022)
- Supportive Care in Cancer
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia (2022)
- Haematologica
(B1 Vertaisarvioimaton kirjoitus tieteellisessä lehdessä ) - Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group (2022)
- European Journal of Haematology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Luovuttajan lymfosyytti-infuusiot allogeenisen kantasolujen siirron jälkihoidossa (2022)
- Duodecim
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Anti-cytokine autoantibodies are rare in chronic graft-versus-host disease (2021)
- Scandinavian Journal of Immunology
(B1 Vertaisarvioimaton kirjoitus tieteellisessä lehdessä ) - B-cell receptor stereotyped subsets and outcome for patients with chronic lymphocytic leukemia in the HOVON 68 trial (2021)
- Journal of Translational Genetics and Genomics
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias (2021)
- Clinical Cancer Research
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )